Clinical Trials · NCT05143723

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Name: Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Unknown
Sponsor: Kuban State Medical University
Enrollment: 102
Start date: Jan 2020
Locations: 1 site, Russia
Primary endpoint: pregnancy rate and clinical pregnancy rate

View Gonadorelin compound reference